A decision between life and death during TNF-α-induced signaling

Journal of Clinical Immunology

Volumn 22, Issue 4, 2002, Pages 185-194

  Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging, NF B; Apoptosis; DAP kinase; Lymphocytes; Mitochondria

Indexed keywords

CASPASE; GAMMA INTERFERON; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; RAF PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VIRUS PROTEIN; APOPTOSIS REGULATORY PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; LEUKOCYTE ANTIGEN; PROTEIN KINASE (CALCIUM,CALMODULIN); TUMOR NECROSIS FACTOR RECEPTOR;

AGING; APOPTOSIS; CELL ACTIVATION; CELL LINE; CELL SURVIVAL; DNA BINDING; DNA DAMAGE; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; INFLAMMATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

AGING; ANTIGENS, CD; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASES; CELL SURVIVAL; HUMAN; MITOCHONDRIA; MODELS, IMMUNOLOGICAL; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; APOPTOSIS REGULATORY PROTEINS; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035996807     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016089607548     Document Type: Review

References (111)

1. Molecular steps of TNF receptor-mediated apoptosis
2. Death receptors: Signaling and modulation
3. T cell life and death signaling via TNF-receptor family members
4. Two TNF receptors
5. Two tumor necrosis factor receptors: Structure and function
6. Identification of a 60-kDa tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses
7. Early events in TNF signaling: A story of associations and dissociations
8. Transducing signals of life and death
9. Tumor necrosis factor receptor-structure and function
10. Suicide by order: Some open questions about the cell-killing activities of the TNF ligand and receptor families
11. Cell death induction by receptors of the TNF family: Towards a molecular understanding
12. Increased cytokine production in mononuclear cells of healthy elderly people
13. Increased TNF-α-induced apoptosis in lymphocytes from aged humans: Changes in TNF-α receptor expression and activation of caspases
14. Molecular steps of death receptor and mitochondrial pathways of apoptosis
15. Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans
16. Molecular steps of cell suicide: An insight into immune senescence
17. I-Flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis
18. Inhibition of death receptor signals by cellular FLIP
19. A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1-induced apoptosis
20. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
21. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
22. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa-B activation prevents cell death
23. An essential role for NF-κB in preventing TNF-α-induced cell death
24. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF-2-dependent pathway
25. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
26. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal of addition of erythropoietin
27. Death in 2000 ways
28. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
29. Endogenous inhibitors of caspases
30. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
31. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60
32. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
33. Overexpression of the p80 TNFR leads to TNF-dependent apoptosis, nuclear factor-kappa B activation
34. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells
35. TNFR-80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60
36. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the p55-kDa TNF receptor
37. Induction of apoptosis in mature T cells by tumor necrosis factor
38. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40, and CD30: A role of TNFR1 activation by endogenous membrane-anchored TNF
39. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
40. The death domain kinase RIP mediates the TNF-induced NF-kappa B signal
41. A crucial role for p80 TNF-R2 in amplifying p60 TNF-RI apoptosis signals in T lymphocytes
42. Function and activation of NF-κB in the immune system
43. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses
44. The NF-κB IκB proteins: New discoveries and insights
45. Control of IκB-α proteolysis by site-specific, signal induced phosphorylation
46. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
47. Direct phosphorylation of IκB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate
48. Activators and target genes of Rel/NF-kB transcription factors
49. How NF-κB is activated: The role of the IkB kinase (IKK) complex
50. NF-κB at the crossroads of life and death
51. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa-B activation prevents cell death
52. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor-κB activation and prevention of apoptosis
53. IKKβ is essential for protecting T cells from TNFα-induced apoptosis
54. Embryonic lethality and liver degeneration in mice acking the RelA component of NF-κB
55. Severe liver degeneration in mice lacking the IκB kinase 2 gene
56. IAPs block apoptotic events induced by caspase-8 and cytocrome c by direct inhibition of distinct caspases
57. Involvement of two NF-κB binding elements in TNF-α, CD40, and Epstein-Barr virus latent membrane protein 1-mediated induction of inhibitor of apoptosis protein 2 gene
58. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase-8 activation
59. Suppression of apoptosis in mammalian cells by NIAP and a related family of IAP genes
60. NF-κB-regulated xiap gene expression protects endothelial cells from TNF-α-induced apoptosis
61. A single BIR domain of XIAP sufficient for inhibiting caspases
62. Inhibition of JNK activation through NF-κB target genes
63. Induction of gadd45β by NF-κB down-regulates proapoptotic JNK signaling
64. Genotoxic stress-response genes and growth arrest genes. Gad, MyD, and other genes induced by treatments eliciting growth arrest
65. Characterization of A1, a novel hematopoietic-specific early-response gene with sequence similarity to bcl-2
66. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis
67. NF-κB-mediated up-regulation of Bcl-X and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
68. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
69. Tumor necrosis factor-induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampus neurons
70. The Rel/NF-κB family directly activates expression of the apoptotic inhibitor Bcl-x (L)
71. Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines
72. Cleavage of death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
73. CD30-dependent degradation of TRAF-2: Implications for negative regulation of TRAF signaling and the control of cell survival
74. Translocation of TRAF proteins regulates apoptosis threshold of cells
75. TRAF1 is a substrate of caspases activated during TNF-α-induced apoptosis
76. The human TNFTRAF1 is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-jun N-terminal kinase
77. Blocking caspase-3-mediated proteolysis of IKKβ suppresses TNF-α-induced apoptosis
78. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
79. cIAP-1 is cleaved by caspases to produce a proapoptotic C-terminal fragments
80. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
81. Modulation of cell death by Bcl-XL through caspase interaction
82. Acceleration of cell death after the cleavage of Bcl-XL protein by casopase-3 like proteases
83. Corpse clearance defines the meaning of cell death
84. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
85. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
86. TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibition by E1B 19K
87. Inhibition of mitochondrial respiratory chain complex by TNF results in cytochrome c release, membrane permeability transition, and apoptosis
88. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition
89. Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of mitochondrial permeability transition
90. P53 and tumor necrosis factor-α regulate the expression of a mitochondrial channel protein
91. The coordinate release of cytochrome "c" during apoptosis is rapid, complete and kinetically invariant
92. Mitochondrial permeability transition triggers lymphocyte apoptosis
93. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
94. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
95. Bcl-x (L) prevents the initial decrease in mitochondrial potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis
96. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis
97. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis
98. 2
99. Tumor necrosis factor-α induces superoxide anion production in mitochondria of L929 cells
100. A cell death-promoting kinase
101. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
102. DAP-kinase participates in TNF-α- and Fas-induced apoptosis and its function requires the death domain
103. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage
104. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression
105. Tumor necrosis factor-α-induced apoptosis in T cell subsets from aged humans. Receptor expression and downstream signaling events
106. A road to ruines: An insight into immunosenscence
107. TNF-α-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis
108. The age-related changes in DNA binding activity of AP-1, NF-κB, and Oct-1 transcription factors in lymphocytes from rats
109. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT
110. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging
111. Decreased proteosome-mediated degradation in T cells from the elderly: A role in immune senescence